SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Automation/Robot

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2112292

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2112292

Medical Robots Market by Product & Services, Type (Surgical, Rehabilitation, Hospital, Pharmacy), End User, and Region - Global Forecasts to 2031

PUBLISHED:
PAGES: 379 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The global medical robots market is projected to reach USD 41.7 billion in 2031 from USD 20.6 billion in 2026, at a CAGR of 15.1% during the forecast period.

Scope of the Report
Years Considered for the Study2026-2031
Base Year2025
Forecast Period2026-2031
Units ConsideredValue (USD billion)
SegmentsProducts & Services, Type, End User, and Region
Regions coveredNorth America, Europe, APAC, LATAM, MEA

The medical robots market is expected to witness strong growth, driven by a combination of clinical, technological, and healthcare automation factors. The rising prevalence of chronic diseases, growing geriatric population, and increasing demand for minimally invasive and precision-based procedures continue to support the adoption of robotic-assisted solutions across healthcare settings. Technological advancements in surgical robotics, rehabilitation robots, hospital and pharmacy automation systems, and non-invasive radiosurgery platforms have improved procedural accuracy, workflow efficiency, medication management, and patient outcomes, thereby accelerating adoption among hospitals, clinics, pharmacies, and rehabilitation centers.

Medical Robots Market - IMG1

Furthermore, the growing need to minimize medication errors, reduce procedural variability, optimize healthcare workflows, and address workforce constraints is contributing to market expansion. These trends are expected to sustain strong growth momentum across both developed and emerging economies; however, stringent regulatory requirements, high system costs, maintenance expenses, and the need for specialized training may restrain adoption to some extent over the forecast period.

"The robotic systems segment is expected to account for the highest market share during the forecast period."

Based on products & services, the medical robots market is segmented into robotic systems, instruments & accessories, and services. The robotic systems segment is projected to account for the highest market share during the forecast period. The high share in this segment can be attributed to the growing focus on adopting technologically advanced surgical robots and robotic-assisted platforms among end users. The increasing demand for precision-based, minimally invasive procedures and the integration of AI, imaging, navigation, and data-driven capabilities are further supporting the adoption of advanced robotic systems. In addition, expanding hospital investments in automation and next-generation robotic platforms are expected to strengthen demand for robotic systems across surgical, rehabilitation, radiosurgery, and hospital automation applications.

"The surgical robotic system segment is estimated to hold the largest share of the medical robots market by type."

Based on type, the medical robots market is segmented into surgical robotic systems, rehabilitation robotic systems, radiosurgery robotic systems, hospital robotic systems, and pharmacy robotic systems. The surgical robotic systems have been further segmented by application into soft tissue surgery (general surgery, gynecological surgery, urological surgery and other applications) and hard tissue surgery (knee & hip surgery, spine surgery, and other applications).

The surgical robotic systems segment accounted for the largest share of the medical robots market in 2025. This segment is expected to witness significant growth due to the increasing demand for surgeries, rising global surgical volumes, and growing clinical acceptance of surgical robots. The expanding adoption of minimally invasive procedures, improved surgeon control, enhanced visualization, and higher procedural precision are further supporting the uptake of surgical robotic systems across hospitals and specialty surgical centers.

"The ambulatory surgery centers segment is expected to register the highest growth during the forecast period."

Based on end user, the medical robots market is segmented into hospitals & clinics, ambulatory surgery centers, pharmacies, rehabilitation centers, and other end users. The ambulatory surgery centers segment is projected to witness the highest growth rate during the forecast period. Growth in this segment is primarily driven by the increasing shift of suitable surgical procedures from inpatient hospital settings to outpatient care environments, supported by the potential for lower treatment costs, shorter patient stays, and faster recovery timelines. The rising demand for efficient, high-quality, and minimally invasive surgical care is encouraging ambulatory surgery centers to adopt advanced robotic-assisted technologies.

"Asia Pacific is projected to register the highest growth in the medical robots market during the forecast period."

The global medical robots market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2025, Asia Pacific is expected to register the highest growth in the medical robots market during the forecast period. Factors such as the increasing adoption of surgical robots, a large patient pool, rising disposable incomes, and growing willingness to spend on advanced healthcare solutions are expected to support market growth in the region. In addition, rapid technological adoption, advancements in the healthcare sector, expansion of private healthcare facilities, and government focus on improving healthcare infrastructure are further expected to drive the growth of the medical robots market in Asia Pacific.

Breakdown of primary interviews:

  • By Supply Side: Tier 1 (35%), Tier 2 (40%), and Tier 3 (25%)
  • By Designation: C-level Executives (45%), Directors (35%), and Others (20%)
  • By Region: North America (27%), Europe (25%), Asia Pacific (30%), Latin America (8%), and Middle East and Africa (10%)

The prominent players in this market are Intuitive Surgical, Inc (US), Stryker (US), Becton, Dickinson and Company (US), Medtronic (Ireland), Omnicell, LLC (US), Zimmer Biomet (US), Smith & Nephew (UK), Ekso Bionics Holdings, Inc. (US), ARxIUM (Canada), Asensus Surgical (US), Renishaw Plc (UK), ZAP Surgical Systems, Inc. (US), KUKA SE & Co. KGaA (Germany), CMR Surgical (UK), Accuray Incorporated (US), DIH Medical (Switzerland), Johnson & Johnson (US), Cyberdyne Inc. (Japan), Lifeward, Inc. (Israel), Relay Robotics (US), Aethon, Inc. (US), Xenex Disinfection Services, Inc. (US), Stereotaxis, Inc. (US), PROCEPT BioRobotics Corporation (US), and Globus Medical (US). Players adopted organic as well as inorganic growth strategies such as acquisitions, product launches, expansions, agreements & collaborations, and approvals to increase their offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

Research Coverage

The report studies the medical robots market based on product & service, type, end user, and region. The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total medical robots market. The report forecasts the revenue of market segments with respect to five major regions.

Reasons to Buy the Report

The report provides valuable insights for market leaders and new entrants in the medical robots industry, offering approximate revenue figures for the overall market and its subsegments. It assists stakeholders in understanding the competitive landscape, enabling them to better position their businesses and develop effective go-to-market strategies. Additionally, the report highlights key market drivers, restraints, challenges, and opportunities, helping stakeholders gauge the current state of the market

This report provides insights into the following pointers:

  • Analysis of key drivers (aging population and rising chronic diseases, technological advancements, increasing need for automation in healthcare, improving reimbursement scenario, and advancements in healthcare funding & infrastructure, and growing need to minimize medication errors), restraints (high cost of robotic systems and stringent regulatory requirements), opportunities (growth opportunities in emerging markets, and novel application) and challenge (patient and provider acceptance).
  • Market Penetration: It provides detailed information on the product portfolios offered by major players in the global medical robots market. The report covers various segments, including product & service, type, region, and end user.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the medical robots market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of medical robot solutions across regions.
  • Market Diversification: Exhaustive information about solutions, untapped regions, recent developments, and investments in the medical robots market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and capabilities of the leading players in the medical robots market.
Show more
Product Code: MD 2257

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED FOR STUDY
  • 1.4 CURRENCY
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES
    • 1.6.1 REFINEMENTS IN SCOPE
    • 1.6.2 COVERAGE OF NEW PLAYERS
    • 1.6.3 UPDATED MARKET DEVELOPMENTS OF PROFILED PLAYERS
    • 1.6.4 UPDATED FINANCIAL INFORMATION/PRODUCT PORTFOLIOS OF PLAYERS
    • 1.6.5 UPDATED GEOGRAPHIC ANALYSIS

2 EXECUTIVE SUMMARY

  • 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS IN MEDICAL ROBOTS MARKET
  • 2.4 HIGH-GROWTH SEGMENTS
  • 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 MEDICAL ROBOTS MARKET OVERVIEW
  • 3.2 MEDICAL ROBOTS MARKET, BY REGION
  • 3.3 ASIA PACIFIC MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE AND COUNTRY
  • 3.4 GEOGRAPHIC SNAPSHOT OF MEDICAL ROBOTS MARKET
  • 3.5 MEDICAL ROBOTS MARKET: DEVELOPING VS. DEVELOPED MARKETS

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Increasing geriatric population with chronic diseases
      • 4.2.1.2 Technological advancements in medical robotics
      • 4.2.1.3 Growing need for automation in healthcare
      • 4.2.1.4 Favorable reimbursement scenario for surgical robots from third-party payers
      • 4.2.1.5 Advancements in healthcare funding and infrastructure
      • 4.2.1.6 Rising need to minimize medication and dispensing errors
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 High cost of medical robotic systems
      • 4.2.2.2 Stringent regulatory requirements and delays in product approvals
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 High growth opportunities in emerging economies
      • 4.2.3.2 Increased use of robotics in novel applications
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Need to ensure patient and provider acceptance
  • 4.3 UNMET NEEDS AND WHITE SPACES
    • 4.3.1 UNMET NEEDS IN MEDICAL ROBOTS MARKET
    • 4.3.2 WHITE SPACE OPPORTUNITIES
  • 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
    • 4.4.1 INTERCONNECTED MARKETS
    • 4.4.2 CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 BARGAINING POWER OF SUPPLIERS
    • 5.1.2 BARGAINING POWER OF BUYERS
    • 5.1.3 THREAT OF NEW ENTRANTS
    • 5.1.4 THREAT OF SUBSTITUTES
    • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.2 MACROECONOMIC OUTLOOK
    • 5.2.1 INTRODUCTION
    • 5.2.2 GDP TRENDS AND FORECAST
    • 5.2.3 TRENDS IN GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY
  • 5.3 REIMBURSEMENT SCENARIO ANALYSIS
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 ECOSYSTEM ANALYSIS
  • 5.6 PRICING ANALYSIS
    • 5.6.1 AVERAGE SELLING PRICE TREND, BY REGION
    • 5.6.2 AVERAGE SELLING PRICE TREND OF MEDICAL ROBOTS, BY TYPE
  • 5.7 TRADE ANALYSIS
    • 5.7.1 IMPORT DATA FOR HS CODE 901890
    • 5.7.2 EXPORT DATA FOR HS CODE 901890
  • 5.8 KEY CONFERENCES & EVENTS, 2026-2027
  • 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.10 CASE STUDY ANALYSIS
    • 5.10.1 CASE STUDY 1: DR. MOHIT BHANDARI PERFORMS WORLD'S FIRST TRANSCONTINENTAL ROBOTIC BARIATRIC SURGERY USING SSI MANTRA
    • 5.10.2 CASE STUDY 2: SUTTER HEALTH PERFORMS FIRST US ROBOTIC SINGLE-PORT NIPPLE-SPARING MASTECTOMY
    • 5.10.3 CASE STUDY 3: ST JOHN OF GOD GEELONG EXPANDS ACCESS TO ADVANCED ROBOTIC SURGERY
  • 5.11 INVESTMENT AND FUNDING SCENARIO
  • 5.12 IMPACT OF 2025 US TARIFF ON MEDICAL ROBOTS MARKET
    • 5.12.1 INTRODUCTION
    • 5.12.2 KEY TARIFF RATES
    • 5.12.3 PRICE IMPACT ANALYSIS
    • 5.12.4 IMPACT ON COUNTRY/REGION
      • 5.12.4.1 US
      • 5.12.4.2 Europe
      • 5.12.4.3 Asia Pacific
    • 5.12.5 IMPACT ON END-USE INDUSTRIES

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, AND INNOVATIONS

  • 6.1 KEY EMERGING TECHNOLOGIES
    • 6.1.1 ROBOTIC ARMS AND INSTRUMENTS
    • 6.1.2 ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING (ML)
    • 6.1.3 TELEPRESENCE
    • 6.1.4 REHABILITATION ROBOTICS & WEARABLE EXOSKELETON TECHNOLOGIES
    • 6.1.5 PHARMACY AUTOMATION & INTELLIGENT MEDICATION MANAGEMENT
    • 6.1.6 COMPLEMENTARY TECHNOLOGIES
      • 6.1.6.1 Augmented reality (AR) and virtual reality (VR)
      • 6.1.6.2 3D imaging
  • 6.2 TECHNOLOGY/PRODUCT ROADMAP
    • 6.2.1 SHORT-TERM (2025-2027) | FOUNDATION & EARLY COMMERCIALIZATION
    • 6.2.2 MID-TERM (2027-2030) | EXPANSION & STANDARDIZATION
    • 6.2.3 LONG-TERM (2030-2035+) | MASS COMMERCIALIZATION & DISRUPTION
  • 6.3 PATENT ANALYSIS
  • 6.4 IMPACT OF AI/GEN AI ON MEDICAL ROBOTS MARKET
    • 6.4.1 TOP USE CASES AND MARKET POTENTIAL
    • 6.4.2 BEST PRACTICES IN MEDICAL ROBOT DEPLOYMENT AND PROCESSING
    • 6.4.3 CASE STUDIES OF AI IMPLEMENTATION IN MEDICAL ROBOTS MARKET
    • 6.4.4 INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS
    • 6.4.5 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN MEDICAL ROBOTS MARKET

7 REGULATORY LANDSCAPE

  • 7.1 REGIONAL REGULATIONS AND COMPLIANCE
    • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 7.2 REGULATORY FRAMEWORK
    • 7.2.1 NORTH AMERICA
      • 7.2.1.1 US
    • 7.2.2 EUROPE
    • 7.2.3 ASIA PACIFIC
      • 7.2.3.1 Japan
      • 7.2.3.2 China
      • 7.2.3.3 India
      • 7.2.3.4 Latin America
        • 7.2.3.4.1 Brazil
        • 7.2.3.4.2 Mexico
      • 7.2.3.5 Middle East
      • 7.2.3.6 Africa
    • 7.2.4 INDUSTRY STANDARDS
  • 7.3 CERTIFICATIONS, LABELING, & ECO-STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

  • 8.1 DECISION-MAKING PROCESS
  • 8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
    • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.2.2 BUYING CRITERIA
  • 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
  • 8.5 MARKET PROFITABILITY
    • 8.5.1 REVENUE POTENTIAL
    • 8.5.2 COST DYNAMICS
    • 8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS

9 MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE

  • 9.1 INTRODUCTION
  • 9.2 INSTRUMENTS & ACCESSORIES
    • 9.2.1 NEED FOR RECURRENT PURCHASE OF INSTRUMENTS & ACCESSORIES FOR SURGICAL PROCEDURES TO SUPPORT MARKET GROWTH
  • 9.3 ROBOTIC SYSTEMS
    • 9.3.1 INCREASING ADOPTION OF TECHNOLOGICALLY ADVANCED ROBOTIC SYSTEMS TO DRIVE MARKET
  • 9.4 SERVICES
    • 9.4.1 INCREASED DEMAND FOR ANNUAL MAINTENANCE CONTRACTS, TECHNICAL SUPPORT, AND USER TRAINING TO PROPEL MARKET

10 MEDICAL ROBOTS MARKET, BY TYPE

  • 10.1 INTRODUCTION
  • 10.2 SURGICAL ROBOTIC SYSTEMS
    • 10.2.1 SOFT TISSUE SURGERY
      • 10.2.1.1 General surgery
        • 10.2.1.1.1 Increasing prevalence of diseases to drive market
      • 10.2.1.2 Gynecological surgery
        • 10.2.1.2.1 Increased availability of robotic platforms to increase adoption of robot-assisted gynecological surgeries
      • 10.2.1.3 Urological surgery
        • 10.2.1.3.1 Increasing prevalence of urological cancers to drive market
      • 10.2.1.4 Other soft tissue surgeries
    • 10.2.2 HARD TISSUE SURGERY
      • 10.2.2.1 Knee & hip surgery
        • 10.2.2.1.1 Increasing number of knee & hip replacement surgeries to propel market
      • 10.2.2.2 Spine surgery
        • 10.2.2.2.1 Increasing adoption of robotic systems for spinal surgeries to drive market
      • 10.2.2.3 Other hard tissue surgeries
  • 10.3 REHABILITATION ROBOTIC SYSTEMS
    • 10.3.1 THERAPEUTIC ROBOTIC SYSTEMS
      • 10.3.1.1 Increasing cases of stroke to drive adoption
    • 10.3.2 ASSISTIVE ROBOTIC SYSTEMS
      • 10.3.2.1 Rising geriatric population to support market growth
    • 10.3.3 EXOSKELETON ROBOTIC SYSTEMS
      • 10.3.3.1 Rising patient pool of neurological disorders to support market growth
    • 10.3.4 OTHER REHABILITATION ROBOTIC SYSTEMS
  • 10.4 RADIOSURGERY ROBOTIC SYSTEMS
    • 10.4.1 GROWING ADOPTION OF ADVANCED STEREOTACTIC RADIATION DELIVERY SYSTEMS BY HOSPITALS TO DRIVE MARKET
  • 10.5 HOSPITAL ROBOTIC SYSTEMS
    • 10.5.1 DELIVERY ROBOTIC SYSTEMS
      • 10.5.1.1 Increasing patient population along with shortage of nursing staff to drive adoption
      • 10.5.1.2 Telepresence robotic systems
        • 10.5.1.2.1 Increased adoption of telepresence robotic systems to drive market
      • 10.5.1.3 Diagnostic robotic systems
        • 10.5.1.3.1 Shortage of skilled healthcare professionals to drive adoption
      • 10.5.1.4 Other hospital robotic systems
  • 10.6 PHARMACY ROBOTIC SYSTEMS
    • 10.6.1 ROBOTIC DISPENSING SYSTEMS
      • 10.6.1.1 High adoption of robots to reduce dispensing errors in hospitals to drive market
    • 10.6.2 COMPOUNDING ROBOTIC SYSTEMS
      • 10.6.2.1 Reduce cost per dose of medication and need for medication outsourcing
    • 10.6.3 OTHER PHARMACY ROBOTIC SYSTEMS

11 MEDICAL ROBOTS MARKET, BY END USER

  • 11.1 INTRODUCTION
  • 11.2 HOSPITALS & CLINICS
    • 11.2.1 HIGH NUMBER OF ROBOTIC-ASSISTED SURGERIES PERFORMED TO SUPPORT MARKET GROWTH
  • 11.3 AMBULATORY SURGERY CENTERS
    • 11.3.1 COST-EFFECTIVE TREATMENTS TO SUPPORT MARKET GROWTH
  • 11.4 PHARMACIES
    • 11.4.1 REDUCED MEDICATION ERRORS AND INCREASED EFFICIENCY TO DRIVE ADOPTION
  • 11.5 REHABILITATION CENTERS
    • 11.5.1 INCREASING INCIDENCE OF DISABILITIES TO SUPPORT MARKET GROWTH
  • 11.6 OTHER END USERS

12 MEDICAL ROBOTS MARKET, BY REGION

  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    • 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 12.2.2 US
      • 12.2.2.1 Presence of many established players to support strong adoption of medical robots
    • 12.2.3 CANADA
      • 12.2.3.1 Growing adoption of advanced healthcare solutions to propel market
  • 12.3 EUROPE
    • 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 12.3.2 GERMANY
      • 12.3.2.1 Strong medical infrastructure to propel market growth
    • 12.3.3 UK
      • 12.3.3.1 National NHS expansion to accelerate medical robot adoption
    • 12.3.4 FRANCE
      • 12.3.4.1 Government-backed innovation and hospital adoption to drive growth
    • 12.3.5 ITALY
      • 12.3.5.1 Government support for healthcare innovation to propel market growth
    • 12.3.6 SPAIN
      • 12.3.6.1 Increasing healthcare spending to drive market
    • 12.3.7 REST OF EUROPE
  • 12.4 ASIA PACIFIC
    • 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 12.4.2 JAPAN
      • 12.4.2.1 Domestic innovation and reimbursement support to support market growth
    • 12.4.3 CHINA
      • 12.4.3.1 Government support for healthcare modernization to propel market
    • 12.4.4 INDIA
      • 12.4.4.1 Increasing healthcare investments to boost demand for medical robotic systems
    • 12.4.5 SOUTH KOREA
      • 12.4.5.1 Government investment and high-volume surgical centers to support market growth
    • 12.4.6 AUSTRALIA
      • 12.4.6.1 Rising adoption of robotic-assisted surgery to propel market
    • 12.4.7 REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    • 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 12.5.2 BRAZIL
      • 12.5.2.1 Expanding healthcare infrastructure to support adoption of medical robots
    • 12.5.3 MEXICO
      • 12.5.3.1 Need to reduce medication errors and rising geriatric population to drive market
    • 12.5.4 REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST & AFRICA
    • 12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 12.6.2 GCC COUNTRIES
      • 12.6.2.1 Increasing initiatives to drive demand for surgical robots
    • 12.6.3 REST OF MIDDLE EAST & AFRICA

13 COMPETITIVE LANDSCAPE

  • 13.1 INTRODUCTION
  • 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL ROBOTS MARKET
  • 13.3 REVENUE ANALYSIS, 2021-2025
  • 13.4 MARKET SHARE ANALYSIS, 2025
  • 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 13.5.1 STARS
    • 13.5.2 EMERGING LEADERS
    • 13.5.3 PERVASIVE PLAYERS
    • 13.5.4 PARTICIPANTS
    • 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
      • 13.5.5.1 Company footprint
      • 13.5.5.2 Region footprint
      • 13.5.5.3 Product & service footprint
      • 13.5.5.4 Type footprint
      • 13.5.5.5 End-user footprint
  • 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
    • 13.6.1 PROGRESSIVE COMPANIES
    • 13.6.2 RESPONSIVE COMPANIES
    • 13.6.3 DYNAMIC COMPANIES
    • 13.6.4 STARTING BLOCKS
    • 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
      • 13.6.5.1 Detailed list of key startups/SMEs
      • 13.6.5.2 Competitive benchmarking of key startups/SMEs
  • 13.7 BRAND COMPARISON
  • 13.8 COMPANY VALUATION AND FINANCIAL METRICS
    • 13.8.1 FINANCIAL METRICS
    • 13.8.2 COMPANY VALUATION
  • 13.9 COMPETITIVE SCENARIO
    • 13.9.1 PRODUCT LAUNCHES & APPROVALS
    • 13.9.2 DEALS
    • 13.9.3 EXPANSIONS
    • 13.9.4 OTHER DEVELOPMENTS

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
    • 14.1.1 INTUITIVE SURGICAL, INC.
      • 14.1.1.1 Business overview
      • 14.1.1.2 Products/Solutions/Services offered
      • 14.1.1.3 Recent developments
        • 14.1.1.3.1 Product approvals
        • 14.1.1.3.2 Deals
        • 14.1.1.3.3 Expansions
      • 14.1.1.4 MnM view
        • 14.1.1.4.1 Key strengths
        • 14.1.1.4.2 Strategic choices
        • 14.1.1.4.3 Weaknesses & competitive threats
    • 14.1.2 STRYKER
      • 14.1.2.1 Business overview
      • 14.1.2.2 Products/Solutions/Services offered
      • 14.1.2.3 Recent developments
        • 14.1.2.3.1 Product launches
        • 14.1.2.3.2 Deals
        • 14.1.2.3.3 Expansions
      • 14.1.2.4 MnM view
        • 14.1.2.4.1 Key strengths
        • 14.1.2.4.2 Strategic choices
        • 14.1.2.4.3 Weaknesses and competitive threats
    • 14.1.3 BD
      • 14.1.3.1 Business overview
      • 14.1.3.2 Products/Solutions/Services offered
      • 14.1.3.3 Recent developments
        • 14.1.3.3.1 Product launches
        • 14.1.3.3.2 Deals
        • 14.1.3.3.3 Other developments
      • 14.1.3.4 MnM view
        • 14.1.3.4.1 Key strengths
        • 14.1.3.4.2 Strategic choices
        • 14.1.3.4.3 Weaknesses and competitive threats
    • 14.1.4 MEDTRONIC
      • 14.1.4.1 Business overview
      • 14.1.4.2 Products/Solutions/Services offered
      • 14.1.4.3 Recent developments
        • 14.1.4.3.1 Product approvals
        • 14.1.4.3.2 Deals
        • 14.1.4.3.3 Expansions
      • 14.1.4.4 MnM view
        • 14.1.4.4.1 Key strengths
        • 14.1.4.4.2 Strategic choices
        • 14.1.4.4.3 Weaknesses and competitive threats
    • 14.1.5 OMNICELL, INC.
      • 14.1.5.1 Business overview
      • 14.1.5.2 Products/Solutions/Services offered
      • 14.1.5.3 Recent developments
        • 14.1.5.3.1 Product launches
        • 14.1.5.3.2 Deals
        • 14.1.5.3.3 Expansions
        • 14.1.5.3.4 Other developments
      • 14.1.5.4 MnM view
        • 14.1.5.4.1 Key strengths
        • 14.1.5.4.2 Strategic choices
        • 14.1.5.4.3 Weaknesses and competitive threats
    • 14.1.6 ZIMMER BIOMET
      • 14.1.6.1 Business overview
      • 14.1.6.2 Products/Solutions/Services offered
      • 14.1.6.3 Recent developments
        • 14.1.6.3.1 Product approvals
        • 14.1.6.3.2 Deals
        • 14.1.6.3.3 Other developments
    • 14.1.7 SMITH+NEPHEW
      • 14.1.7.1 Business overview
      • 14.1.7.2 Products/Solutions/Services offered
      • 14.1.7.3 Recent developments
        • 14.1.7.3.1 Product/service launches and enhancements
    • 14.1.8 EKSO BIONICS
      • 14.1.8.1 Business overview
      • 14.1.8.2 Products/Solutions/Services offered
      • 14.1.8.3 Recent developments
        • 14.1.8.3.1 Product approvals
        • 14.1.8.3.2 Deals
        • 14.1.8.3.3 Other developments
    • 14.1.9 ARXIUM
      • 14.1.9.1 Business overview
      • 14.1.9.2 Products/Solutions/Services offered
      • 14.1.9.3 Recent developments
        • 14.1.9.3.1 Product approvals
    • 14.1.10 ASENSUS SURGICAL US, INC. (SUBSIDIARY OF KARL STORZ)
      • 14.1.10.1 Business overview
      • 14.1.10.2 Products/Solutions/Services offered
      • 14.1.10.3 Recent developments
        • 14.1.10.3.1 Product approvals
        • 14.1.10.3.2 Deals
    • 14.1.11 RENISHAW PLC
      • 14.1.11.1 Business overview
      • 14.1.11.2 Products/Services/Solutions offered
      • 14.1.11.3 Recent developments
        • 14.1.11.3.1 Product approvals
    • 14.1.12 SIEMENS HEALTHINEERS AG
      • 14.1.12.1 Business overview
      • 14.1.12.2 Products/Solutions/Services offered
      • 14.1.12.3 Recent developments
        • 14.1.12.3.1 Deals
    • 14.1.13 KUKA AG
      • 14.1.13.1 Business overview
      • 14.1.13.2 Products/Solutions/Services offered
    • 14.1.14 CMR SURGICAL
      • 14.1.14.1 Business overview
      • 14.1.14.2 Products/Services offered
      • 14.1.14.3 Recent developments
        • 14.1.14.3.1 Product approvals
        • 14.1.14.3.2 Deals
        • 14.1.14.3.3 Other developments
    • 14.1.15 ACCURAY INCORPORATED
      • 14.1.15.1 Business overview
      • 14.1.15.2 Products/Solutions/Services offered
      • 14.1.15.3 Recent developments
        • 14.1.15.3.1 Product approvals
        • 14.1.15.3.2 Deals
        • 14.1.15.3.3 Expansions
        • 14.1.15.3.4 Other developments
    • 14.1.16 DIH MEDICAL
      • 14.1.16.1 Business overview
      • 14.1.16.2 Products/Solutions/Services offered
      • 14.1.16.3 Recent developments
        • 14.1.16.3.1 Product approvals
        • 14.1.16.3.2 Deals
        • 14.1.16.3.3 Other developments
    • 14.1.17 JOHNSON & JOHNSON
      • 14.1.17.1 Business overview
      • 14.1.17.2 Products/Solutions/Services offered
      • 14.1.17.3 Recent developments
        • 14.1.17.3.1 Product launches & approvals
        • 14.1.17.3.2 Other developments
    • 14.1.18 CYBERDYNE INC.
      • 14.1.18.1 Business overview
      • 14.1.18.2 Products/Solutions/Services offered
      • 14.1.18.3 Recent developments
        • 14.1.18.3.1 Product approvals
        • 14.1.18.3.2 Deals
        • 14.1.18.3.3 Expansions
    • 14.1.19 LIFEWARD, INC.
      • 14.1.19.1 Business overview
      • 14.1.19.2 Products/Solutions/Services offered
      • 14.1.19.3 Recent developments
        • 14.1.19.3.1 Product approvals
        • 14.1.19.3.2 Deals
    • 14.1.20 GLOBUS MEDICAL
      • 14.1.20.1 Business overview
      • 14.1.20.2 Products/Services/Solutions offered
      • 14.1.20.3 Recent developments
        • 14.1.20.3.1 Product launches & approvals
  • 14.2 OTHER PLAYERS
    • 14.2.1 RELAY ROBOTICS, INC.
  • 14.3 PROCEPT BIOROBOTICS CORPORATION
    • 14.3.1 AETHON, INC. (SUBSIDIARY OF ST ENGINEERING)
    • 14.3.2 XENEX DISINFECTION SERVICES INC.
    • 14.3.3 ZAP SURGICAL SYSTEMS, INC.

15 RESEARCH METHODOLOGY

  • 15.1 RESEARCH DATA
    • 15.1.1 SECONDARY DATA
      • 15.1.1.1 Key data from secondary sources
    • 15.1.2 PRIMARY DATA
      • 15.1.2.1 Key data from primary sources
      • 15.1.2.2 Key industry insights
  • 15.2 MARKET SIZE ESTIMATION
    • 15.2.1 BOTTOM-UP APPROACH
    • 15.2.2 TOP-DOWN APPROACH
    • 15.2.3 BASE NUMBER ESTIMATION
      • 15.2.3.1 Supply-side analysis (revenue share analysis)
      • 15.2.3.2 Company presentations and primary interviews
  • 15.3 MARKET FORECAST APPROACH
  • 15.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 15.5 MARKET SHARE ESTIMATION
  • 15.6 STUDY ASSUMPTIONS
  • 15.7 FACTOR ANALYSIS
  • 15.8 RESEARCH LIMITATIONS
    • 15.8.1 SCOPE-RELATED LIMITATIONS
    • 15.8.2 METHODOLOGY-RELATED LIMITATIONS
  • 15.9 RISK ASSESSMENT

16 APPENDIX

  • 16.1 DISCUSSION GUIDE
  • 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 16.3 CUSTOMIZATION OPTIONS
  • 16.4 RELATED REPORTS
  • 16.5 AUTHOR DETAILS
Show more
Product Code: MD 2257

List of Tables

  • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • TABLE 2 GROWTH RATE IN GERIATRIC POPULATION, BY REGION, 2020 VS. 2050
  • TABLE 3 PER CAPITA NATIONAL INCOME, BY COUNTRY, 2020-2023 (USD)
  • TABLE 4 MEDICAL ROBOTS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 5 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021-2030
  • TABLE 6 CPT CODES AND REIMBURSEMENT ANALYSIS FOR DA VINCI SURGICAL SYSTEM IN US
  • TABLE 7 REGIONAL PRICING ANALYSIS OF MEDICAL ROBOTIC SYSTEMS, BY TYPE, 2025
  • TABLE 8 AVERAGE SELLING PRICE OF MEDICAL ROBOTS, BY TYPE, 2025
  • TABLE 9 IMPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD THOUSAND)
  • TABLE 10 EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD THOUSAND)
  • TABLE 11 MEDICAL ROBOTS MARKET: LIST OF KEY CONFERENCES & EVENTS, 2026-2027
  • TABLE 12 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 13 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR MEDICAL ROBOTS
  • TABLE 14 TOP USE CASES AND MARKET POTENTIAL
  • TABLE 15 MEDICAL ROBOTS MARKET: CASE STUDIES RELATED TO AI IMPLEMENTATION
  • TABLE 16 INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS
  • TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 US FDA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 23 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 24 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
  • TABLE 25 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 26 GLOBAL STANDARDS IN MEDICAL ROBOTS MARKET
  • TABLE 27 CERTIFICATIONS, LABELING, & ECO-STANDARDS IN MEDICAL ROBOTS MARKET
  • TABLE 28 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY END USER
  • TABLE 29 KEY BUYING CRITERIA FOR END USERS
  • TABLE 30 MEDICAL ROBOTS MARKET: UNMET NEEDS/END-USER EXPECTATIONS
  • TABLE 31 MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD MILLION)
  • TABLE 32 MEDICAL ROBOT INSTRUMENTS & ACCESSORIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 33 MEDICAL ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 34 MEDICAL ROBOTIC SYSTEMS MARKET, BY REGION, 2024-2031 (UNITS)
  • TABLE 35 MEDICAL ROBOT SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 36 MEDICAL ROBOTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 37 SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 38 SURGICAL ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 39 SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 40 SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 41 SURGICAL ROBOTIC SYSTEMS MARKET FOR GENERAL SURGERY, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 42 SURGICAL ROBOTIC SYSTEMS MARKET FOR GYNECOLOGICAL SURGERY, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 43 SURGICAL ROBOTIC SYSTEMS MARKET FOR UROLOGICAL SURGERY, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 44 SURGICAL ROBOTIC SYSTEMS MARKET FOR OTHER SOFT TISSUE SURGERIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 45 SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 46 SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 47 SURGICAL ROBOTIC SYSTEMS MARKET FOR KNEE & HIP SURGERY, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 48 SURGICAL ROBOTIC SYSTEMS MARKET FOR SPINE SURGERY, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 49 SURGICAL ROBOTIC SYSTEMS MARKET FOR OTHER HARD TISSUE SURGERIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 50 REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 51 REHABILITATION ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 52 THERAPEUTIC ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 53 ASSISTIVE ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 54 EXOSKELETON ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 55 OTHER REHABILITATION ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 56 RADIOSURGERY ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 57 HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 58 HOSPITAL ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 59 DELIVERY ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 60 TELEPRESENCE ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 61 DIAGNOSTIC ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 62 OTHER HOSPITAL ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 63 PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 64 PHARMACY ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 65 POPULAR ROBOTIC AUTOMATED DISPENSING SYSTEMS AVAILABLE IN MARKET
  • TABLE 66 ROBOTIC DISPENSING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 67 POPULAR COMPOUNDING ROBOTIC SYSTEMS AVAILABLE IN MARKET
  • TABLE 68 COMPOUNDING ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 69 OTHER PHARMACY ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 70 MEDICAL ROBOTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 71 LIST OF RECENTLY INSTALLED ROBOTIC SYSTEMS IN HOSPITALS
  • TABLE 72 MEDICAL ROBOTS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 73 MEDICAL ROBOTS MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 74 MEDICAL ROBOTS MARKET FOR PHARMACIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 75 MEDICAL ROBOTS MARKET FOR REHABILITATION CENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 76 MEDICAL ROBOTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 77 MEDICAL ROBOTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 78 NORTH AMERICA: MEDICAL ROBOTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 79 NORTH AMERICA: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD MILLION)
  • TABLE 80 NORTH AMERICA: MEDICAL ROBOTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 81 NORTH AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 82 NORTH AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 83 NORTH AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 84 NORTH AMERICA: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 85 NORTH AMERICA: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 86 NORTH AMERICA: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 87 NORTH AMERICA: MEDICAL ROBOTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 88 US: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD MILLION)
  • TABLE 89 US: MEDICAL ROBOTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 90 US: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 91 US: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 92 US: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 93 US: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 94 US: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 95 US: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 96 US: MEDICAL ROBOTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 97 CANADA: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD MILLION)
  • TABLE 98 CANADA: MEDICAL ROBOTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 99 CANADA: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 100 CANADA: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 101 CANADA: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 102 CANADA: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 103 CANADA: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 104 CANADA: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 105 CANADA: MEDICAL ROBOTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 106 EUROPE: MEDICAL ROBOTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 107 EUROPE: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD MILLION)
  • TABLE 108 EUROPE: MEDICAL ROBOTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 109 EUROPE: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 110 EUROPE: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 111 EUROPE: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 112 EUROPE: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 113 EUROPE: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 114 EUROPE: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 115 EUROPE: MEDICAL ROBOTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 116 GERMANY: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD MILLION)
  • TABLE 117 GERMANY: MEDICAL ROBOTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 118 GERMANY: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 119 GERMANY: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 120 GERMANY: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 121 GERMANY: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 122 GERMANY: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 123 GERMANY: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 124 GERMANY: MEDICAL ROBOTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 125 UK: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD MILLION)
  • TABLE 126 UK: MEDICAL ROBOTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 127 UK: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 128 UK: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 129 UK: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 130 UK: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 131 UK: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 132 UK: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 133 UK: MEDICAL ROBOTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 134 FRANCE: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD MILLION)
  • TABLE 135 FRANCE: MEDICAL ROBOTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 136 FRANCE: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 137 FRANCE: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 138 FRANCE: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 139 FRANCE: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 140 FRANCE: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 141 FRANCE: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 142 FRANCE: MEDICAL ROBOTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 143 ITALY: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD MILLION)
  • TABLE 144 ITALY: MEDICAL ROBOTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 145 ITALY: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 146 ITALY: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 147 ITALY: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 148 ITALY: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 149 ITALY: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 150 ITALY: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 151 ITALY: MEDICAL ROBOTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 152 SPAIN: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD MILLION)
  • TABLE 153 SPAIN: MEDICAL ROBOTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 154 SPAIN: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 155 SPAIN: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 156 SPAIN: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 157 SPAIN: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 158 SPAIN: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 159 SPAIN: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 160 SPAIN: MEDICAL ROBOTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 161 REST OF EUROPE: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD MILLION)
  • TABLE 162 REST OF EUROPE: MEDICAL ROBOTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 163 REST OF EUROPE: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 164 REST OF EUROPE: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 165 REST OF EUROPE: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 166 REST OF EUROPE: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 167 REST OF EUROPE: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 168 REST OF EUROPE: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 169 REST OF EUROPE: MEDICAL ROBOTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 170 ASIA PACIFIC: MEDICAL ROBOTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 171 ASIA PACIFIC: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024-2031
  • TABLE 172 ASIA PACIFIC: MEDICAL ROBOTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 173 ASIA PACIFIC: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 174 ASIA PACIFIC: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 175 ASIA PACIFIC: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 176 ASIA PACIFIC: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 177 ASIA PACIFIC: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 178 ASIA PACIFIC: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 179 ASIA PACIFIC: MEDICAL ROBOTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 180 JAPAN: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD MILLION)
  • TABLE 181 JAPAN: MEDICAL ROBOTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 182 JAPAN: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 183 JAPAN: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 184 JAPAN: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 185 JAPAN: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 186 JAPAN: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 187 JAPAN: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 188 JAPAN: MEDICAL ROBOTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 189 CHINA: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD MILLION)
  • TABLE 190 CHINA: MEDICAL ROBOTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 191 CHINA: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 192 CHINA: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 193 CHINA: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 194 CHINA: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 195 CHINA: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 196 CHINA: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 197 CHINA: MEDICAL ROBOTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 198 INDIA: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD MILLION)
  • TABLE 199 INDIA: MEDICAL ROBOTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 200 INDIA: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 201 INDIA: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 202 INDIA: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 203 INDIA: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 204 INDIA: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 205 INDIA: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 206 INDIA: MEDICAL ROBOTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 207 SOUTH KOREA: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD MILLION)
  • TABLE 208 SOUTH KOREA: MEDICAL ROBOTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 209 SOUTH KOREA: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 210 SOUTH KOREA: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 211 SOUTH KOREA: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 212 SOUTH KOREA: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 213 SOUTH KOREA: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 214 SOUTH KOREA: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 215 SOUTH KOREA: MEDICAL ROBOTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 216 AUSTRALIA: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD MILLION)
  • TABLE 217 AUSTRALIA: MEDICAL ROBOTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 218 AUSTRALIA: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 219 AUSTRALIA: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 220 AUSTRALIA: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 221 AUSTRALIA: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 222 AUSTRALIA: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 223 AUSTRALIA: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 224 AUSTRALIA: MEDICAL ROBOTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 225 REST OF ASIA PACIFIC: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD MILLION)
  • TABLE 226 REST OF ASIA PACIFIC: MEDICAL ROBOTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 227 REST OF ASIA PACIFIC: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 228 REST OF ASIA PACIFIC: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 229 REST OF ASIA PACIFIC: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 230 REST OF ASIA PACIFIC: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 231 REST OF ASIA PACIFIC: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 232 REST OF ASIA PACIFIC: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 233 REST OF ASIA PACIFIC: MEDICAL ROBOTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 234 LATIN AMERICA: MEDICAL ROBOTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 235 LATIN AMERICA: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD MILLION)
  • TABLE 236 LATIN AMERICA: MEDICAL ROBOTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 237 LATIN AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 238 LATIN AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 239 LATIN AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 240 LATIN AMERICA: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 241 LATIN AMERICA: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 242 LATIN AMERICA: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 243 LATIN AMERICA: MEDICAL ROBOTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 244 BRAZIL: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD MILLION)
  • TABLE 245 BRAZIL: MEDICAL ROBOTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 246 BRAZIL: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 247 BRAZIL: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 248 BRAZIL: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 249 BRAZIL: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 250 BRAZIL: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 251 BRAZIL: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 252 BRAZIL: MEDICAL ROBOTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 253 MEXICO: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD MILLION)
  • TABLE 254 MEXICO: MEDICAL ROBOTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 255 MEXICO: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 256 MEXICO: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 257 MEXICO: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 258 MEXICO: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 259 MEXICO: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 260 MEXICO: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 261 MEXICO: MEDICAL ROBOTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 262 REST OF LATIN AMERICA: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD MILLION)
  • TABLE 263 REST OF LATIN AMERICA: MEDICAL ROBOTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 264 REST OF LATIN AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 265 REST OF LATIN AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 266 REST OF LATIN AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 267 REST OF LATIN AMERICA: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 268 REST OF LATIN AMERICA: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 269 REST OF LATIN AMERICA: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 270 REST OF LATIN AMERICA: MEDICAL ROBOTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 271 MIDDLE EAST & AFRICA: MEDICAL ROBOTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 272 MIDDLE EAST & AFRICA: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD MILLION)
  • TABLE 273 MIDDLE EAST & AFRICA: MEDICAL ROBOTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 274 MIDDLE EAST & AFRICA: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 275 MIDDLE EAST & AFRICA: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 276 MIDDLE EAST & AFRICA: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 277 MIDDLE EAST & AFRICA: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 278 MIDDLE EAST & AFRICA: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 279 MIDDLE EAST & AFRICA: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 280 MIDDLE EAST & AFRICA: MEDICAL ROBOTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 281 GCC COUNTRIES: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD MILLION)
  • TABLE 282 GCC COUNTRIES: MEDICAL ROBOTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 283 GCC COUNTRIES: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 284 GCC COUNTRIES: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 285 GCC COUNTRIES: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 286 GCC COUNTRIES: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 287 GCC COUNTRIES: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 288 GCC COUNTRIES: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 289 GCC COUNTRIES: MEDICAL ROBOTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 290 REST OF MIDDLE EAST & AFRICA: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD MILLION)
  • TABLE 291 REST OF MIDDLE EAST & AFRICA: MEDICAL ROBOTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 292 REST OF MIDDLE EAST & AFRICA: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 293 REST OF MIDDLE EAST & AFRICA: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 294 REST OF MIDDLE EAST & AFRICA: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 295 REST OF MIDDLE EAST & AFRICA: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 296 REST OF MIDDLE EAST & AFRICA: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 297 REST OF MIDDLE EAST & AFRICA: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 298 REST OF MIDDLE EAST & AFRICA: MEDICAL ROBOTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 299 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN MEDICAL ROBOTS MARKET
  • TABLE 300 SURGICAL ROBOTS MARKET: DEGREE OF COMPETITION
  • TABLE 301 HOSPITAL & PHARMACY ROBOTIC SYSTEMS MARKET: INTENSITY OF COMPETITIVE RIVALRY
  • TABLE 302 MEDICAL ROBOTS MARKET: REGION FOOTPRINT
  • TABLE 303 MEDICAL ROBOTS MARKET: PRODUCT & SERVICE FOOTPRINT
  • TABLE 304 MEDICAL ROBOTS MARKET: TYPE FOOTPRINT
  • TABLE 305 MEDICAL ROBOTS MARKET: END-USER FOOTPRINT
  • TABLE 306 MEDICAL ROBOTS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 307 MEDICAL ROBOTS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 308 MEDICAL ROBOTS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-MAY 2026
  • TABLE 309 MEDICAL ROBOTS MARKET: DEALS, JANUARY 2022-MAY 2026
  • TABLE 310 MEDICAL ROBOTS MARKET: EXPANSIONS, JANUARY 2022-MAY 2026
  • TABLE 311 MEDICAL ROBOTS MARKET: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2026
  • TABLE 312 INTUITIVE SURGICAL, INC.: COMPANY OVERVIEW
  • TABLE 313 INTUITIVE SURGICAL, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 314 INTUITIVE SURGICAL OPERATIONS, INC.: PRODUCT APPROVALS, JANUARY 2022-MAY 2026
  • TABLE 315 INTUITIVE SURGICAL OPERATIONS, INC.: DEALS, JANUARY 2022-MAY 2026
  • TABLE 316 INTUITIVE SURGICAL OPERATIONS, INC: EXPANSIONS, JANUARY 2022-MAY 2026
  • TABLE 317 STRYKER: COMPANY OVERVIEW
  • TABLE 318 STRYKER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 319 STRYKER: PRODUCT LAUNCHES, JANUARY 2022-MAY 2026
  • TABLE 320 STRYKER: DEALS, JANUARY 2022-MAY 2026
  • TABLE 321 STRYKER: EXPANSIONS, JANUARY 2022-MAY 2026
  • TABLE 322 BD: COMPANY OVERVIEW
  • TABLE 323 BD: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 324 BD: PRODUCT APPROVALS, JANUARY 2022-MAY 2026
  • TABLE 325 BD: DEALS, JANUARY 2022-MAY 2026
  • TABLE 326 BD: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2026
  • TABLE 327 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 328 MEDTRONIC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 329 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2022-MAY 2026
  • TABLE 330 MEDTRONIC: DEALS, JANUARY 2022-MAY 2026
  • TABLE 331 MEDTRONIC: EXPANSIONS, JANUARY 2022-MAY 2026
  • TABLE 332 OMNICELL, INC.: COMPANY OVERVIEW
  • TABLE 333 OMNICELL, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 334 OMNICELL, INC.: PRODUCT LAUNCHES, JANUARY 2022-MAY 2026
  • TABLE 335 OMNICELL, INC.: DEALS, JANUARY 2022-MAY 2026
  • TABLE 336 OMNICELL, LLC: EXPANSIONS, JANUARY 2022-MAY 2026
  • TABLE 337 OMNICELL, INC.: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2026
  • TABLE 338 ZIMMER BIOMET: COMPANY OVERVIEW
  • TABLE 339 ZIMMER BIOMET: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 340 ZIMMER BIOMET: PRODUCT APPROVALS, JANUARY 2022-MAY 2026
  • TABLE 341 ZIMMER BIOMET: DEALS, JANUARY 2022-MAY 2026
  • TABLE 342 ZIMMER BIOMET: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2026
  • TABLE 343 SMITH+NEPHEW: COMPANY OVERVIEW
  • TABLE 344 SMITH+NEPHEW: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 345 SMITH+NEPHEW: PRODUCT & SERVICE LAUNCHES AND ENHANCEMENTS, JANUARY 2022-MAY 2026
  • TABLE 346 EKSO BIONICS: COMPANY OVERVIEW
  • TABLE 347 EKSO BIONICS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 348 EKSO BIONICS: PRODUCT APPROVALS, JANUARY 2022-MAY 2026
  • TABLE 349 EKSO BIONICS: DEALS, JANUARY 2022-MAY 2026
  • TABLE 350 EKSO BIONICS: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2026
  • TABLE 351 ARXIUM: COMPANY OVERVIEW
  • TABLE 352 ARXIUM: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 353 ARXIUM: PRODUCT APPROVALS, JANUARY 2022-MAY 2026
  • TABLE 354 ASENSUS SURGICAL INC.: COMPANY OVERVIEW
  • TABLE 355 ASENSUS SURGICAL INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 356 ASENSUS SURGICAL US, INC.: PRODUCT APPROVALS, JANUARY 2022-MAY 2026
  • TABLE 357 ASENSUS SURGICAL US, INC.: DEALS, JANUARY 2022-MAY 2026
  • TABLE 358 RENISHAW PLC.: COMPANY OVERVIEW
  • TABLE 359 RENISHAW PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 360 RENISHAW PLC: PRODUCT APPROVALS, JANUARY 2022-MAY 2026
  • TABLE 361 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
  • TABLE 362 SIEMENS HEALTHINEERS AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 363 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022-MAY 2026
  • TABLE 364 KUKA AG: COMPANY OVERVIEW
  • TABLE 365 KUKA AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 366 CMR SURGICAL: COMPANY OVERVIEW
  • TABLE 367 CMR SURGICAL: PRODUCTS/SERVICES OFFERED
  • TABLE 368 CMR SURGICAL: PRODUCT APPROVALS, JANUARY 2022-MAY 2026
  • TABLE 369 CMR SURGICAL: DEALS, JANUARY 2022-MAY 2026
  • TABLE 370 CMR SURGICAL: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2026
  • TABLE 371 ACCURAY INCORPORATED: COMPANY OVERVIEW
  • TABLE 372 ACCURAY INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 373 ACCURAY INCORPORATED: PRODUCT APPROVALS, JANUARY 2022-MAY 2026
  • TABLE 374 ACCURAY INCORPORATED: DEALS, JANUARY 2022-MAY 2026
  • TABLE 375 ACCURAY INCORPORATED: EXPANSIONS, JANUARY 2022-MAY 2026
  • TABLE 376 ACCURAY INCORPORATED: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2026
  • TABLE 377 DIH MEDICAL: COMPANY OVERVIEW
  • TABLE 378 DIH MEDICAL: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 379 DIH MEDICAL: PRODUCT APPROVALS & LAUNCHES, JANUARY 2022-MAY 2026
  • TABLE 380 DIH MEDICAL: DEALS, JANUARY 2022-MAY 2026
  • TABLE 381 DIH MEDICAL: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2026
  • TABLE 382 JOHNSON & JOHNSON: COMPANY OVERVIEW
  • TABLE 383 JOHNSON & JOHNSON: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 384 JOHNSON & JOHNSON: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-MAY 2026
  • TABLE 385 JOHNSON & JOHNSON: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2026
  • TABLE 386 CYBERDYNE INC.: COMPANY OVERVIEW
  • TABLE 387 CYBERDYNE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 388 CYBERDYNE, INC.: PRODUCT APPROVALS, JANUARY 2022-MAY 2026
  • TABLE 389 CYBERDYNE, INC.: DEALS, JANUARY 2022-MAY 2026
  • TABLE 390 CYBERDYNE INC: EXPANSIONS, JANUARY 2022-MAY 2026
  • TABLE 391 LIFEWARD, INC.: COMPANY OVERVIEW
  • TABLE 392 LIFEWARD, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 393 LIFEWARD, INC.: PRODUCT APPROVALS, JANUARY 2022-MAY 2026
  • TABLE 394 LIFEWARD, INC.: DEALS, JANUARY 2022-MAY 2026
  • TABLE 395 GLOBUS MEDICAL: COMPANY OVERVIEW
  • TABLE 396 GLOBUS MEDICAL: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 397 GLOBUS MEDICAL: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-MAY 2026
  • TABLE 398 RELAY ROBOTICS, INC.: COMPANY OVERVIEW
  • TABLE 399 PROCEPT BIOROBOTICS CORPORATION: COMPANY OVERVIEW
  • TABLE 400 AETHON, INC. (SUBSIDIARY OF ST ENGINEERING): COMPANY OVERVIEW
  • TABLE 401 XENEX DISINFECTION SERVICES, INC.: COMPANY OVERVIEW
  • TABLE 402 ZAP SURGICAL SYSTEMS, INC.: COMPANY OVERVIEW
  • TABLE 403 RISK ASSESSMENT: MEDICAL ROBOTS MARKET

List of Figures

  • FIGURE 1 MARKET SCENARIO
  • FIGURE 2 MEDICAL ROBOTS MARKET, 2026-2031 (USD MILLION)
  • FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL ROBOTS MARKET, 2022-2026
  • FIGURE 4 DISRUPTIVE TRENDS IMPACTING GROWTH OF MEDICAL ROBOTS MARKET
  • FIGURE 5 HIGH-GROWTH SEGMENTS IN MEDICAL ROBOTS MARKET, 2026-2031
  • FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 7 INCREASING VOLUME OF SURGERIES AND RISING GERIATRIC POPULATION TO DRIVE MARKET
  • FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING STUDY PERIOD
  • FIGURE 9 INSTRUMENTS & ACCESSORIES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2025
  • FIGURE 10 INDIA TO REGISTER HIGHEST CAGR FROM 2026 TO 2031
  • FIGURE 11 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
  • FIGURE 12 MEDICAL ROBOTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 13 MEDICAL ROBOTS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 14 MEDICAL ROBOTS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 15 MEDICAL ROBOTS MARKET: ECOSYSTEM
  • FIGURE 16 MEDICAL ROBOTS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 17 INVESTMENT/VENTURE CAPITAL SCENARIO IN MEDICAL ROBOTS MARKET, 2022-2025
  • FIGURE 18 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR MEDICAL ROBOTS MARKET, JANUARY 2015-DECEMBER 2025
  • FIGURE 19 TOP PATENT APPLICANT COUNTRIES FOR MEDICAL ROBOTS (JANUARY 2015-DECEMBER 2025)
  • FIGURE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
  • FIGURE 21 KEY BUYING CRITERIA FOR END USERS
  • FIGURE 22 NUMBER OF NEW GYNECOLOGICAL CANCER CASES, 2022 VS. 2045
  • FIGURE 23 NUMBER OF NEW UROLOGICAL CANCER CASES, 2022 VS. 2045
  • FIGURE 24 HIP REPLACEMENT SURGICAL PROCEDURES, BY COUNTRY, 2013 VS. 2023
  • FIGURE 25 KNEE REPLACEMENT SURGICAL PROCEDURES, BY COUNTRY, 2013 VS. 2023
  • FIGURE 26 INDIA TO REGISTER HIGHEST GROWTH IN MEDICAL ROBOTS MARKET DURING FORECAST PERIOD
  • FIGURE 27 NORTH AMERICA: MEDICAL ROBOTS MARKET SNAPSHOT
  • FIGURE 28 ASIA PACIFIC: MEDICAL ROBOTS MARKET SNAPSHOT
  • FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL ROBOTS MARKET, 2021-2025
  • FIGURE 30 MARKET SHARE ANALYSIS OF KEY PLAYERS IN SURGICAL ROBOTS MARKET, 2025
  • FIGURE 31 MARKET SHARE ANALYSIS FOR KEY PLAYERS IN HOSPITAL & PHARMACY ROBOTIC SYSTEMS MARKET, 2025
  • FIGURE 32 MEDICAL ROBOTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 33 MEDICAL ROBOTS MARKET: COMPANY FOOTPRINT
  • FIGURE 34 MEDICAL ROBOTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
  • FIGURE 35 MEDICAL ROBOTS MARKET: BRAND COMPARISON
  • FIGURE 36 EV/EBITDA OF KEY VENDORS
  • FIGURE 37 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 38 INTUITIVE SURGICAL, INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 39 STRYKER: COMPANY SNAPSHOT (2025)
  • FIGURE 40 BD: COMPANY SNAPSHOT (2025)
  • FIGURE 41 MEDTRONIC: COMPANY SNAPSHOT (2025)
  • FIGURE 42 OMNICELL, INC. COMPANY SNAPSHOT (2025)
  • FIGURE 43 ZIMMER BIOMET: COMPANY SNAPSHOT (2025)
  • FIGURE 44 SMITH+NEPHEW: COMPANY SNAPSHOT (2025)
  • FIGURE 45 EKSO BIONICS: COMPANY SNAPSHOT (2025)
  • FIGURE 46 RENISHAW PLC: COMPANY SNAPSHOT (2025)
  • FIGURE 47 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2025)
  • FIGURE 48 KUKA AG: COMPANY SNAPSHOT (2025)
  • FIGURE 49 ACCURAY INCORPORATED: COMPANY SNAPSHOT (2025)
  • FIGURE 50 DIH MEDICAL: COMPANY SNAPSHOT (2025)
  • FIGURE 51 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2025)
  • FIGURE 52 CYBERDYNE INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 53 LIFEWARD, INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 54 GLOBUS MEDICAL: COMPANY SNAPSHOT
  • FIGURE 55 RESEARCH DESIGN
  • FIGURE 56 PRIMARY SOURCES
  • FIGURE 57 BOTTOM-UP APPROACH
  • FIGURE 58 TOP-DOWN APPROACH
  • FIGURE 59 SUPPLY-SIDE MEDICAL ROBOTS MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 60 REVENUE SHARE ANALYSIS ILLUSTRATION: STRYKER
  • FIGURE 61 SUPPLY-SIDE ANALYSIS: MEDICAL ROBOTS MARKET (2025)
  • FIGURE 62 MEDICAL ROBOTS MARKET: CAGR PROJECTIONS
  • FIGURE 63 DATA TRIANGULATION METHODOLOGY
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!